Pipeline
Overview
JADO is focusing its initial drug development efforts in two therapeutic areas:
- Mast cell derived allergic diseases (eg atopic dermatitis, asthma)
- Infectious diseases (eg influenza, HIV, tuberculosis)
We decided to concentrate on these applications because of the great need for patients to have more effective treatments but with fewer side effects. A growing need for novel therapeutics based on new mechanisms of action makes these indications also very commercially attractive.
RAFT Intervention Technology provides the following key differentiating factors:
- Novel drug chemistry
- Novel mode-of-action (for validated and novel targets)
- High drug efficacy
- High target selectivity
- Reduced dosing

